Jnj sotck.

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - …

Jnj sotck. Things To Know About Jnj sotck.

Review the current JNJ dividend history, yield and Johnson and Johnson stock split data to decide if it is a good investment for your portfolio this year.Dec 1, 2023 · Very Negative. Source. Headline. California Public Employees Retirement System Decreases Holdings in Johnson & Johnson (NYSE:JNJ) marketbeat.com - November 18 at 6:05 AM. 21 Analysts Have This to Say About Johnson & Johnson. markets.businessinsider.com - November 17 at 7:44 PM. The stock price of Johnson & Johnson has outperformed the broader indices over the last month or so. While the S&P500 index has seen a rise of 1% over the last one month, JNJ stock is up around 5%.MedTech. Johnson & Johnson MedTech innovates at the intersection of biology and technology. With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex diseases.The stock price of Johnson & Johnson reached its all-time high of around $180 just last month before a recent sell-off in pharmaceutical stocks resulted in JNJ falling to $165 levels currently.

Dec 1, 2023 · Johnson & Johnson (NYSE:JNJ) pays an annual dividend of $4.76 per share and currently has a dividend yield of 3.14%. The company has been increasing its dividend for 61 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 35.34%. Current and historical p/e ratio for Johnson & Johnson (JNJ) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure.

As I pointed out in another article, I consider JNJ fully valued at about $170 to $180 per share, so the market has priced in a significant increase in talc-related liabilities, with the stock now ...Johnson & Johnson historical stock charts and prices, analyst ratings, financials, and today’s real-time JNJ stock price. ... Johnson & Johnson JNJ (U.S.: NYSE) search. View All companies. AT ...

Share price: $9.89. Value: $26,018,533. Share of portfolio: 0.011%. Related: 15 Genius Things I Learned at Lunch With Warren Buffett. February 3, 2018 Fremont / CA / USA - Johnson & Johnson logo ...JNJ Stock Summary. JNJ has a market capitalization of $354,471,776,795 -- more than approximately 99.54% of US stocks. JOHNSON & JOHNSON's stock had its IPO on January 1, 1986, making it an older stock than 93.05% of US equities in our set.Published July 24, 2023. Getty Images. Johnson & Johnson ( JNJ) will spin off at least 80.1% of its shares in consumer health company Kenvue ( KVUE) through an exchange offer, the company said ...California State Teachers' Retirement System, or Calsters, cut positions in AMC Entertainment, NIO, Spotify, and Johnson & Johnson in the third quarter. Warren Buffett is known for owning shares ...The latest Johnson & Johnson stock prices, stock quotes, news, and JNJ history to help you invest and trade smarter.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

See Johnson & Johnson stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... Based on 23 analysts giving stock ratings to JNJ in the past 3 months. …

JNJ | Complete Johnson & Johnson stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field.The 19 analysts offering 1 year price forecasts for JNJ have a max estimate of — and a min estimate of —. Analyst rating Based on 23 analysts giving stock ratings to JNJ in the past 3 months.Dec 1, 2023 · Very Negative. Source. Headline. California Public Employees Retirement System Decreases Holdings in Johnson & Johnson (NYSE:JNJ) marketbeat.com - November 18 at 6:05 AM. 21 Analysts Have This to Say About Johnson & Johnson. markets.businessinsider.com - November 17 at 7:44 PM. Contact Investor Relations Questions? Please contact us: 1-800-950-5089 [email protected]

Feb 27, 2023 · JNJ’s revenue is expected to increase 3.1% year-over-year to $97.85 billion in 2023. Its EPS is expected to grow 3.6% year-over-year to $10.52 in 2023. It surpassed EPS estimates in all four trailing quarters. JNJ’s shares have lost marginally intraday to close the last trading session at $155.97. JNJ’s POWR Ratings reflect this promising ... The Johnson & Johnson (NYSE: JNJ) stock price could have some new headwinds ahead of it. Shares of the multinational are down 2.01% over the past five days at the time of writing and down more at ...In early April, when the $8.9bn bankruptcy settlement was first reported, JNJ stock leapt from ~$158, to $163, a gain of 3%. In early March, JNJ stock had hit a two-and-a-half year low of ~$151.Johnson & Johnson (JNJ) Q4 2022 Earnings Call Transcript. JNJ earnings call for the period ending December 31, 2022. Motley Fool Transcribing | ...J&J stock price quote (NYSE: JNJ), historical charts, related news, stock analyst insights and more to help you make the right investing decisions.

Mar 1, 2023 · Johnson & Johnson is well-prepared to weather a potential recession. See why I believe JNJ stock is an attractive low-risk pick in the current environment.

Get the latest Kenvue Inc (KVUE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.JNJ: Johnson & Johnson industry comparisons. Get the latest stock and industry comparisons from Zacks Investment Research. ... That means you want to buy stocks with a Zacks Rank #1 or #2, ...Oct 14, 2023 · Johnson & Johnson is a drug stock for conservative investors. Tipranks lists 14 analysts, only 5 of whom are telling clients to buy it. Johnson & Johnson remains conservative, but that’s no ... Very Negative. Source. Headline. California Public Employees Retirement System Decreases Holdings in Johnson & Johnson (NYSE:JNJ) marketbeat.com - November 18 at 6:05 AM. 21 Analysts Have This to Say About Johnson & Johnson. markets.businessinsider.com - November 17 at 7:44 PM.Johnson & Johnson ( NYSE:JNJ) is currently trading at a decade-low forward P/E ratio. This is particularly interesting since the healthcare behemoth rarely trades at a discount. With the company boasting six decades of consecutive annual dividend increases and the stock featuring a multi-year high yield following its recent decline, the buying ...31 Ago 2023 ... What's Happening With Johnson & Johnson Stock? ... Johnson & Johnson stock (NYSE: JNJ) has seen a 3% fall in a month, compared to a 2% fall for ...Looking more closely at the company’s 10-Q, it looks like Berkshire raised $7.0 billion from stock sales during the third quarter—some of which may have been fueled by ongoing sales of BYD.Get the latest Johnson & Johnson (JNJ) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.On Friday, Johnson & Johnson announced plans to spin off its consumer-products division — famous for household-name but not-very-lucrative brands like Tylenol, Band-Aid and Neutrogena — into a ...

Stock analysis for Johnson & Johnson (JNJ:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Johnson & Johnson (JNJ.NYSE) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Johnson & Johnson | Nyse: JNJ | Nyse.

This 12% rise for JNJ stock since late 2019 can primarily be attributed to 1.Johnson & Johnson’s revenue growth of 16% to $95 billion over the last twelve months, compared to $82 billion in 2019 ...Contact Investor Relations. Questions? Please contact us: 1-800-950-5089 [email protected] & Johnson ( NYSE:JNJ) is currently trading at a decade-low forward P/E ratio. This is particularly interesting since the healthcare behemoth rarely trades at a discount. With the company boasting six decades of consecutive annual dividend increases and the stock featuring a multi-year high yield following its recent decline, the buying ...Oct 14, 2023 · Johnson & Johnson is a drug stock for conservative investors. Tipranks lists 14 analysts, only 5 of whom are telling clients to buy it. Johnson & Johnson remains conservative, but that’s no ... NEW BRUNSWICK, N.J., August 16, 2023--Johnson & Johnson (NYSE: JNJ) today announced the final exchange ratio for its previously announced split-off exchange offer to Johnson & Johnson shareholders ...Apr 17, 2023 · When I wrote my last article, JNJ stock was trading close to $150, which I think is a compelling valuation. As the stock approaches $170, I no longer consider JNJ a buy and therefore changed my ... J&J stock price quote (NYSE: JNJ), historical charts, related news, stock analyst insights and more to help you make the right investing decisions.Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...

Oct 24, 2023, 2:14 pm EDT. Shares of Johnson & Johnson approached a 52-week low Tuesday, just over a week after the drugmaker reported better than expected third-quarter financial results and ...Oct 14, 2023 · Johnson & Johnson is a drug stock for conservative investors. Tipranks lists 14 analysts, only 5 of whom are telling clients to buy it. Johnson & Johnson remains conservative, but that’s no ... JNJ Sales Forecast. Next quarter’s sales forecast for JNJ is $21.00B with a range of $20.19B to $21.24B. The previous quarter’s sales results were $21.34B. JNJ beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 44.95% of the time in the same period.Instagram:https://instagram. nyse wetdoc tickerfljp stockcfp certification cost NVIDIA Corporation Common Stock. O. Realty Income Corporation Common Stock. $51.56 -0.50 -0.96%. Find the latest historical data for Johnson & Johnson Common Stock (JNJ) at Nasdaq.com.Aug 16, 2023 · NEW BRUNSWICK, N.J., August 16, 2023--Johnson & Johnson (NYSE: JNJ) today announced the final exchange ratio for its previously announced split-off exchange offer to Johnson & Johnson shareholders ... thursday football newshrl stock dividend Jul 24, 2023 · The exchange offer will permit Johnson & Johnson shareholders to exchange some, all or none of their shares of Johnson & Johnson common stock for shares of Kenvue common stock at a 7% discount, subject to an upper limit of 8.0549 shares of Kenvue common stock per share of Johnson & Johnson common stock tendered and accepted in the exchange offer. Contact Investor Relations Questions? Please contact us: 1-800-950-5089 [email protected] invest in our future Dec 1, 2023 · Get the latest Johnson & Johnson (JNJ) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. View live Johnson & Johnson chart to track its stock's price action. Find market predictions, JNJ financials and market news.News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating Performance Dividends Ownership Executive $158.38 +3.72 (2.41%) View Full Chart As of Dec 1, 2023 4:00pm...